Menu
Search
|

Menu

Close
X

AbbVie Inc ABBV.N (New York Stock Exchange)

80.02 USD
+1.27 (+1.61%)
As of Feb 22
chart
Previous Close 78.75
Open 79.16
Volume 1,601,803
3m Avg Volume 1,899,442
Today’s High 80.18
Today’s Low 78.25
52 Week High 122.00
52 Week Low 75.77
Shares Outstanding (mil) 1,504.22
Market Capitalization (mil) 120,367.40
Forward P/E 21.52
Dividend (Yield %) 1.07 ( 5.35 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.72 Mean rating from 18 analysts

KEY STATS

Revenue (mm, USD)
FY18
32,753
FY17
28,216
FY16
25,638
EPS (USD)
FY18
3.576
FY17
3.547
FY16
3.641
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
21.52
35.75
Price to Sales (TTM)
vs sector
3.67
9.77
Price to Book (MRQ)
vs sector
--
4.49
Price to Cash Flow (TTM)
vs sector
13.62
26.04
Total Debt to Equity (MRQ)
vs sector
--
16.68
LT Debt to Equity (MRQ)
vs sector
--
13.13
Return on Investment (TTM)
vs sector
--
12.61
Return on Equity (TTM)
vs sector
--
13.81

EXECUTIVE LEADERSHIP

Richard Gonzalez
Chairman of the Board, Chief Executive Officer, Since 2013
Salary: $1,638,460.00
Bonus: $4,331,250.00
Michael Severino
President, Vice Chairman, Since 2018
Salary: $1,004,460.00
Bonus: $1,955,070.00
Carlos Alban
Vice Chairman, Chief Commercial Officer, Since 2018
Salary: $947,469.00
Bonus: $1,836,220.00
Laura Schumacher
Vice Chairman, External Affairs and Chief Legal Officer, Since 2018
Salary: $1,008,530.00
Bonus: $1,954,550.00
Robert Michael
Chief Financial Officer, Senior Vice President, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

1 N Waukegan Rd
NORTH CHICAGO   IL   60064-1802

Phone: +1847.9327900

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

SPONSORED STORIES